Drug Discovery Today

5.2k papers and 228.2k indexed citations i.

About

The 5.2k papers published in Drug Discovery Today in the last decades have received a total of 228.2k indexed citations. Papers published in Drug Discovery Today usually cover Molecular Biology (2.5k papers), Computational Theory and Mathematics (831 papers) and Oncology (526 papers) specifically the topics of Computational Drug Discovery Methods (829 papers), Monoclonal and Polyclonal Antibodies Research (271 papers) and RNA Interference and Gene Delivery (239 papers). The most active scholars publishing in Drug Discovery Today are Prashant Kesharwani, Sean Ekins, Michael S. Kinch, Jagat R. Kanwar and Tingjun Hou.

In The Last Decade

Fields of papers published in Drug Discovery Today

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Drug Discovery Today. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Drug Discovery Today

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Drug Discovery Today. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Drug Discovery Today with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025